Armistice Capital »

Bioaffinity Technologies shares owned by Armistice Capital

Quarter-by-quarter ownership of Bioaffinity Technologies (BIAFW) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Bioaffinity Technologies

Tip: Access up to 7 years of quarterly data

All positions including Bioaffinity Technologies held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioaffinity Technologies by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $19k 204k 0.09
2023-06-30 $105k 204k 0.51
2023-03-31 $61k 204k 0.30
2022-12-31 $86k 204k 0.42
2022-09-30 $72k 204k 0.35

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Bioaffinity Technologies

Citadel Advisors
Warberg Asset Management

View all funds holding Bioaffinity Technologies